Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease

Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and subsequently undertreated. Studies have demonstrated that meibomian gland dysfunction (MGD) is a leading cause of the development and progression of evaporative DED, caused by a deficient tear film lipid layer that leads to increased tear evaporation. New and emerging treatments with novel mechanisms of action are being investigated that manage the signs and symptoms of DED associated with MGD and offer the potential for improved quality of life and greater preservation of vision. In this continuing education monograph, experts in the field review the pathophysiology, burden, and risk factors associated with DED and MGD and assess the efficacy and safety of current and emerging therapies.